Clinical Trials Directory

Trials / Completed

CompletedNCT02858544

Concussion in Motor Vehicle Accidents: The Concussion Identification Index

Status
Completed
Phase
Study type
Observational
Enrollment
1,790 (actual)
Sponsor
Clionsky Neuro Systems Inc. · Industry
Sex
All
Age
10 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The primary goal of this study is to provide clinicians with a brief, patient self-administer instrument yielding a single composite score that reliably correlates with objective findings on standardized neurocognitive assessment for concussion.

Detailed description

This Phase 2 study, Concussion in Motor Vehicle Accidents - The Concussion Identification Index (CIDI), focuses on the psychometric properties of the relationship between acute injury events, i.e. head impact, loss of consciousness (LOC), and post-traumatic amnesia (PTA), commonly reported post-crash signs and symptoms, and neurocognitive outcomes. Cohort 1 is the validation group and will be used to confirm the optimal cut-off score of the Concussion Identification Index (CIDI) with the score on the ImPACT. Cohort 2 is the cross-validation group.

Conditions

Interventions

TypeNameDescription
OTHERThe Concussion Identification IndexPatient completion of the Concussion Identification Index, a report of crash characteristics, injuries sustained, and post-accident neurological signs and symptoms
OTHERImPACTPatient- completed computerized neurocognitive test battery

Timeline

Start date
2013-11-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2016-08-08
Last updated
2016-08-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02858544. Inclusion in this directory is not an endorsement.